Distal axonopathy in an alsin-deficient mouse model

Human Molecular Genetics

Volumn 16, Issue 23, 2007, Pages 2911-2920

  Deng, Han Xiang ^a   Zhai, Hong ^a   Fu, Ronggen ^a   Shi, Yong ^a   Gorrie, George H ^a   Yang, Yi ^a   Liu, Erdong ^a   Dal Canto, Mauro C ^a   Mugnaini, Enrico ^a   Siddique, Teepu ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Cell and Molecular Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALSIN PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DATA ANALYSIS; GENE MUTATION; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; MOUSE; NERVE FIBER; NEUROPATHY; NONHUMAN; PATHOGENESIS; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; PYRAMIDAL TRACT; SPASTIC PARESIS;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; BRAIN; DISEASE MODELS, ANIMAL; EXONS; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MOTOR NEURONS; MUTATION; PREGNANCY; SPINAL CORD; SUPEROXIDE DISMUTASE;

MUS;

EID: 35748930544     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm251     Document Type: Article

References (42)

1. Hughes, J.T. (1982) Pathology of amyotrophic lateral sclerosis. Adv. Neurol., 36, 61-74.
2. Lacomblez, L., Bensimon, G., Leigh, P.N., Guillet, P. and Meininger, V. (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet, 347, 1425-1431.
3. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.-X. et al. (1993) Mutations in Cu,Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
4. Deng, H.-X., Hentati, A., Tainer, J.A., Iqbal, Z., Cayabyab, A., Hung, W.Y., Getzoff, E.D., Hu, P., Herzfeldt, B., Roos, R.P. et al. (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science, 261, 1047-1051.
5. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.-X. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772-1775.
6. Reaume, A.G., Elliott, J.L., Hoffman, E.K., Kowall, N.W., Ferrante, R.J., Siwek, D.F., Wilcox, H.M., Flood, D.G., Beal, M.F., Brown, R.H., Jr et al. (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet., 13, 43-47.
7. Yang, Y., Hentati, A., Deng, H.-X., Dabbagh, O., Sasaki, T., Hirano, M., Hung, W.Y., Ouahchi, K., Yan, J., Azim, A.C. et al. (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet., 29, 160-165.
8. Hadano, S., Hand, C.K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R.S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R. et al. (2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet., 29, 166-173.
9. Eymard-Pierre, E., Lesca, G., Dollet, S., Santorelli, F.M., di Capua, M., Bertini, E. and Boespflug-Tanguy, O. (2002) Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am. J. Hum. Genet., 71, 518-527.
10. Gros-Louis, F., Meijer, I.A., Hand, C.K., Dube, M.P., MacGregor, D.L., Seni, M.H., Devon, R.S., Hayden, M.R., Andermann, F., Andermann, E. et al. (2003) An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred. Ann. Neurol., 53, 144-145.
11. Devon, R.S., Helm, J.R., Rouleau, G.A., Leitner, Y., Lerman-Sagie, T., Lev, D. and Hayden, M.R. (2003) The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin. Genet., 64, 210-215.
12. Kress, J.A., Kuhnlein, P., Winter, P., Ludolph, A.C., Kassubek, J., Muller, U. and Sperfeld, A.D. (2005) Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann. Neurol., 58, 800-803.
13. Panzeri, C, De Palma, C., Martinuzzi, A., Daga, A., De Polo, G., Bresolin, N., Miller, C.C., Tudor, E.L., Clementi, E. and Bassi, M.T. (2006) The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain, 129 (Pt 7), 1710-1719.
14. Eymard-Pierre, E., Yamanaka, K., Haeussler, M., Kress, W., Gauthier-Barichard, F., Combes, P., Cleveland, D.W. and Boespflug-Tanguy, O. (2006) Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis. Ann. Neurol., 59, 976-980.
15. Dal Canto, M.C. and Gurney, M.E. (1995) Neuropathological changes 'in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial lateral sclerosis (FALS). Brain Res., 676, 25-40.
16. Shibata, N., Hirano, A., Kobayashi, M., Siddique, T., Deng, H.-X., Hung, W.Y., Kato, T. and Asayama, K. (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol., 55, 481-490.
17. Deng, H.-X., Shi, Y., Furukawa, Y., Zhai, H., Fu, R., Liu, E., Gorrie, G.H., Khan, M.S., Hung, W.Y., Bigio, E.H. et al. (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl. Acad. Sci. USA, 103, 7142-7147.
18. Furukawa, Y., Fu, R., Deng, H.-X., Siddique, T. and O'Halloran, T.V. (2006) Disulfide cross-linked protein represents a significant fraction of ALS-associated SOD1 aggregates in spinal cords of model mice. Proc. Natl. Acad. Sci. USA, 103, 7148-7153.
19. Strong, M.J., Kesavapany, S. and Pant, H. (2005) The pathobiology of amyotrophic lateral sclerosis: A proteinopathy? J. Neuropathol. Exp. Neurol., 64, 649-664 (Review).
20. Brown, R.H. (1995) Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice. Cell, 80, 687-692.
21. Kanekura, K., Hashimoto, Y., Niikura, T., Aiso, S., Matsuoka, M. and Nishimoto, I. (2004) Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J. Biol. Chem., 279, 19247-19256.
22. Kanekura, K., Hashimoto, Y., Kita, Y., Sasabe, J., Aiso, S., Nishimoto, I. and Matsuoka, M.A. (2005) Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J. Biol. Chem., 280, 4532-4543.
23. Cai, H., Lin, X., Xie, C., Laird, F.M., Lai, C., Wen, H., Chiang, H.C., Shim, H., Farah, M.H. and Hoke, A. (2005) Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J. Neurosci., 25, 7567-7574.
24. Hadano, S., Benn, S.C., Kakuta, S., Otomo, A., Sudo, K., Kunita, R., Suzuki-Utsunomiya, K., Mizumura, H., Shefner, J.M., Cox, G.A. et al. (2006) Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum. Mol. Genet., 15, 233-250.
25. Yamanaka, K., Miller, T.M., McAlonis-Downes, M., Chun, S.J. and Cleveland, D.W. (2006) Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Ann. Neurol., 60, 95-104.
26. Devon, R.S., Orban, P.C., Gerrow, K., Barbieri, M.A., Schwab, C., Cao, L.P., Helm, J.R., Bissada, N., Cruz-Aguado, R., Davidson, T.L. et al. (2006) Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc. Natl. Acad. Sci. USA, 103, 9595-9600.
27. Ben Hamida, M., Hentati, F. and Ben Hamida, C. (1990) Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain, 113, 347-363.
28. De Olmos, J.S., Beltramino, C.A. and de Olmos de Lorenzo, S. (1994) Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol. Teratol., 16, 545-561.
29. Switzer, R.C. (2000) Application of silver degeneration stains for neurotoxicity testing. Toxicol. Pathol., 28, 70-83 (Review).
30. Lai, C., Me, C., McCormack, S.G., Chiang, H.C., Michalak, M.K., Lin, X., Chandran, J., Shim, H., Shimoji, M., Cookson, M.R. et al. (2006) Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking. J. Neurosci., 26, 11798-11806.
31. Otomo, A., Hadano, S., Okada, T., Mizumura, H., Kunita, R., Nishijima, H., Showguchi-Miyata, J., Yanagisawa, Y., Kohiki, E., Suga, E. et al. (2003) ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum, Mol. Genet. 12, 1671-1687.
32. Yamanaka, K., Vande Velde, C., Eymard-Pierre, E., Bertini, F., Boespflug-Tanguy, O. and Cleveland, D.W. (2003) Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc. Natl. Acad Sci., 100, 16041-16046.
33. Topp, J.D., Gray, N.W., Gerard, R.D. and Horazdovsky, B.F. (2004) Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J. Biol. Chem. 279, 24612-24623.
34. Lin, X., Shim, H. and Cai, H. (2006) Deficiency in the ALS2 gene does not affect the motor neuron degeneration in SODI (G93A) transgenic mice. Neurobiol. Aging, 28, 1628-1630.
35. Steward, O., Zheng, B., Ho, C., Anderson, K. and Tessier-Lavigne, M. (2004) The dorsolateral corticospinal tract in mice: An alternative route for corticospinal input to caudal segments following dorsal column lesions. J. Comp. Neurol., 472, 463-477.
36. Armand, J. (1982) The origin, course and terminations of corticospinal fibers in various mammals. Prog. Brain Res., 57, 329-360.
37. Muir, G.D. and Whishaw, I.Q. (1999) Complete locomotor recover following corticospinal tract lesions: Measurement of ground reaction forces during overground locomotion in rats. Behav. Brain Res., 103 45-53.
38. Yang, H.W. and Lemon, R.N. (2003) An electron microscopic examination of the corticospinal projection to the cervical spinal cord in the rat: lack of evidence for cortico-motoneuronal synapses. Exp. Brain Res. 149, 458-469.
39. Armstrong, D.M. (1986) Supraspinal contributions to the initiation and control of locomotion in the cat. Prog. Neurobiol., 26, 273-361.
40. Tower, S.S. (1940) Pyramidal lesions in the monkey. Brain, 63 36-90.
41. Lawrence, G.D. and Kuypers, H.G. (1968) The functional organization of the motor system in the monkey. I. The effects of bilateral pyramidal lesions. Brain, 91, 1-14.
42. Rainier, S. and Fink, J.K. (2005) Hereditary spastic paraplegia: clinical features and animal models. In Ledoux, M. (ed.), Animal Models of Movement Disorders. Elsevier Academic Press, New York, Chapter L2, pp. 687-690.